Subtype
Malignant Neck Neoplasm
CI-CAN-00001148Explore in graph →
607 active trials11 approved drugs67 evidence items
- NCIt
- C4940
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001148Explore in graph →
Clinical trials
2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00798655 | Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer | completed | Phase 2 | 46 | Robert FerrisOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT03300765 | Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer | unknown | Phase 2 | 20 | Xiayun He, MDOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT02831179 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor |
| withdrawn |
| Phase 1 |
| 0 |
| Vanderbilt-Ingram Cancer CenterOTHER |
| 0 |
| Sep 28, 2017 |
| clinicaltrials |
| NCT03282617 | Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 1 | 55 | National University Hospital, SingaporeOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01700647 | Breath Testing in Early and Late Larynx Cancer | completed | — | 30 | Royal Brisbane and Women's HospitalOTHER_GOV | 1 | Sep 12, 2017 | clinicaltrials |
| NCT02280811 | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | completed | Phase 1 / Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Sep 6, 2017 | clinicaltrials |
| NCT02456701 | Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 | completed | Phase 1 | 7 | Celldex TherapeuticsINDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT03268785 | Intra-operative Rapid Identification of Lymph Node and Parathyroid | unknown | N/A | 200 | Xijing HospitalOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02437513 | NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration | terminated | — | 2 | ProTiP MedicalINDUSTRY | 0 | Aug 24, 2017 | clinicaltrials |
| NCT01434394 | Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer(EAGLE) | completed | Phase 2 / Phase 3 | 243 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT02778412 | ctDNA in Patients With Thyroid Nodules | terminated | — | 66 | Pathway GenomicsINDUSTRY | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00953420 | Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes(CADEN) | completed | Phase 2 | 20 | Baylor College of MedicineOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT01326559 | Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) | completed | Phase 2 | 33 | Hong Kong Nasopharyngeal Cancer Study Group LimitedOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT01767961 | Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Aug 10, 2017 | clinicaltrials |
| NCT03239769 | Compare the Aesthetic Effect of Different Thyroidectomies | completed | N/A | 120 | Peking University Cancer Hospital & InstituteOTHER | 0 | Aug 9, 2017 | clinicaltrials |
| NCT02114658 | Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients | completed | Phase 2 | 18 | BayerINDUSTRY | 1 | Aug 3, 2017 | clinicaltrials |
| NCT02726282 | Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02561533 | Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma | completed | N/A | 53 | University of AarhusOTHER | 1 | Jul 14, 2017 | clinicaltrials |
| NCT03213587 | Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | unknown | Phase 2 | 51 | Zhejiang Cancer HospitalOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT03210389 | A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT02375451 | Effect of Childhood Radioiodine Therapy on Salivary Function | completed | — | 70 | Boston Children's HospitalOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT01392222 | Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others | completed | — | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2017 | clinicaltrials |
| NCT03003182 | A Study of Nasopharyngeal Carcinoma From Guangdong | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| NCT03158324 | Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 | unknown | Phase 2 | 52 | National University Hospital, SingaporeOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| NCT02442661 | Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer | completed | — | 103 | University of Colorado, DenverOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT01927887 | Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study | completed | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | completed | Phase 2 | 263 | Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT03170804 | Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer | unknown | — | 200 | Aventura Hospital and Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03167385 | Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00359645 | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | completed | Phase 3 | 1,993 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC(De-ESCALaTE) | unknown | Phase 3 | 334 | University of WarwickOTHER | 3 | May 8, 2017 | clinicaltrials |
| NCT02196168 | Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 3, 2017 | clinicaltrials |
| NCT01539655 | Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib(Vandetanib) | completed | Phase 1 | 34 | SanofiINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT02109250 | CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice(CaprelsaReg) | completed | — | 10 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT00519896 | Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer | completed | Phase 2 | 35 | University of WashingtonOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | completed | Phase 1 | 28 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01267240 | Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 2 | Apr 14, 2017 | clinicaltrials |
| NCT00970359 | Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 | completed | N/A | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01865838 | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | terminated | N/A | 19 | National Cancer Centre, SingaporeOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT00970502 | Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 15 | Johnny KaoOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT01256385 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy(MAESTRO HN) | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 2 | Mar 27, 2017 | clinicaltrials |
| NCT01365208 | New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer | completed | — | 70 | Chinese University of Hong KongOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT03087695 | Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma | unknown | — | 200 | Taichung Veterans General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00729157 | Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2017 | clinicaltrials |
| NCT01534897 | Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00095628 | SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2017 | clinicaltrials |
| NCT01342978 | Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time(HOTSPOT) | completed | — | 242 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Mar 3, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 3, 2017source: clinicaltrials